Further, recent studies employing next-generation sequencing described the presence of mutations of KIT, WT1, TET1, ASXL1, SF3B1 and EZH2 [32] as well as NPM1, NRAS, and DNMT3A [33] in EM AML. This evidence concerns the gene NRAS and acute myeloid leukemia.